Odyssey Therapeutics, Inc. (ODTX) - Latest Market Data

Price & Market Data

Price: $17.56

Daily Change: +$0.06 / 0.34%

Daily Range: $16.50 - $18.43

Market Cap: $828,378,176

Daily Volume: 368,916

Performance Metrics

1 Week: -0.28%

1 Month: 5.68%

3 Months: 5.68%

6 Months: 5.68%

1 Year: 5.68%

YTD: 5.68%

About Odyssey Therapeutics, Inc. (ODTX)

Your daily market report for Odyssey Therapeutics, Inc. (ODTX). Price: 17.56, daily change: +$0.06 / 0.34%. Market cap: 828,378,176. Full performance analysis from YTD to 52-week.

Details

Odyssey Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops medicines for autoimmune and inflammatory diseases. The company pipeline includes OD-001, an oral small molecule inhibitor of receptor-interacting protein kinase 2, which is in phase 2a trial for the treatment of ulcerative colitis; OD-002, an oral small molecule SLC15A4 inhibitor designed to block TLR7/8/9-mediated pathogenic inflammatory responses activation of interferon regulatory factor 5 (IRF5); OD-003, a protein therapeutic designed to agonize tumor necrosis factor receptor 2 selectively on Treg; a TSLP/IL-33 bispecific antagonist; an oral small molecule interleukin-1 receptor–associated kinase 4 scaffolding inhibitor; and a small molecule inhibitor of IRF5. The company was incorporated in 2021 and is headquartered in Boston, Massachusetts.

Selected stocks

HMH Holding Inc. (HMH)

DAX Germany ETF (DAX)

Kailera Therapeutics, Inc. (KLRA)

RF Acquisition Corp II (RFAI)

BHAV Acquisition Corp (BHAV)